|Articles|October 14, 2020
From Data Integrity Regulations to Pharma 4.0
Author(s)Thermo Fisher Scientific
This white paper provides a vendor’s perspective on recent trends in regulations and the potential future direction for the industry referred to as “Pharma 4.0”.
Trending on LCGC International
1
How Should You Respond to FDA 483 Observations?
2
LC-MS/MS Links Vitamin D Levels to Sleep Timing
3
Analytical Procedure Lifecycle Approaches in Accordance With ICH Q14 and ICH Q2(R2): Opportunity Knocks or Just Another Challenge and Headache? (Part 2)
4
HPLC, PTR-ToF-MS Enable AI Grading of White Tea
5